Nahl Share Discussion Threads

[tiltonboy] 27/9/2023 10:35

Not many following it.

Allenby has fair value at 65p.

[ali47fish] 27/9/2023 07:57

no one commenting about the update-why

[ali47fish] 26/9/2023 07:38

update sounds good

[blackhorse23] 01/9/2023 15:49

Out with profit & bought GATC

[ali47fish] 25/8/2023 10:57

why the spike up -frustrating when we are in the dark with aim shares

[volsung] 16/8/2023 12:35

Bought a few

[johnhemming] 26/7/2023 12:32

That strikes me as just over 3% (3.4ish). Hence we should have a TR-1 in the next couple of days.

[someuwin] 26/7/2023 11:24

Huge 1.6m trade gone through £755,000 worth.

[someuwin] 26/7/2023 10:50

Allenby note summary...

"Strategy on track. Full year results expected to be in line

In its first half trading update, NAHL continued to progress across all principal aspects of its strategic plan, with an encouraging 13% reduction in net debt. Although the personal injury (PI) market in the UK contracted by around 1%, NAHL’s enquiry levels were comparable with H1 22 suggesting a continuation of market share gains. Activity levels in Critical Care continued to grow with a 15% increase in expert witness reports issued and a 5% increase in initial needs assessments (INAs) completed in the six months. Despite the uncertain macroeconomic environment, full year results are expected to be in line with market expectations and we continue to believe the share price seriously undervalues the business. Fair value remains at 65p."

[loglorry1] 26/7/2023 10:21

Don't be daft Blackhorse the results were pretty good and at least inline. The number that matters is how much debt they are paying off which was impressive. Once the debt is down then they can sell the claims buiness and clear the rest of the debt and be net cash. That leaves them with very profitable Bush which is worth at least the market cap right now.

[blackhorse23] 26/7/2023 08:07

Disappointing results

[grahamg8] 26/7/2023 07:36

Well I ripped into NAH on the presentation of the final results, my post 741 22/3/23. These are a joy to behold in comparison. I just hope that the full year figures can be presented in an equally clear manner.

[someuwin] 25/5/2023 11:00

Allenby

NAHL Group plc: AGM update: Continued progress in scaling the business for future growth

NAHL’s AGM statement released today, is encouraging as management continues to scale the businesses for further growth. As a result, the Board’s expectations for the full year remain unchanged and we make no alterations to our forecasts. As a reminder, these still call for a c.13% increase in adjusted PBT in 2023, c.170% in FY24 and a further c.70% in FY25. Our current fair value remains at 65p but this is likely to rise as the Group delivers on its significant potential.

[someuwin] 25/5/2023 07:23

25 May 2023

NAHL Group PLC

("NAHL" or the "Group")

AGM Statement

James Saralis, CEO of NAHL (AIM: NAH), a leading marketing and services business focused on the UK consumer legal market, will make the following statement at the Group's Annual General Meeting being held at 10 a.m. today:

"Since the publication of the 2022 Final Results on 22 March 2023, the Group has continued to make progress in scaling both of its divisions.

"In Consumer Legal Services, the number of personal injury enquiries generated in the first four months of the year (the "Period") was consistent with last year (excluding tariff-only road traffic accident ("RTA") claims, which we ceased processing in February 2022) and the Group's market-leading brand, National Accident Helpline, delivered a good performance in organic search. The business saw higher than expected supply of RTA enquiries in the Period, which may be due to recent consolidation in the industry, which has resulted in the division placing increased levels of RTA work into its wholly-owned law firm, National Accident Law ("NAL"). The Group will continue to utilise its agile placement model to manage volumes.

"The Group continues to make progress in scaling NAL and placed 8% more enquiries into NAL in the Period. Cash received from settled claims in NAL increased by 108%.

"In Critical Care, Bush & Co. has grown both Case Management and Expert Witness services, and

issued 25% more Expert Witness reports in the Period than the same period last year. As a result of its marketing and business development activities, the pipeline of work for Bush & Co. remains strong for the remainder of the year.

"Finally, in April and as previously announced, the Group completed the sale of its conveyancing business, Homeward Legal. The subsidiary was considered non-core to the Group's principal focus in Consumer Legal Services and Critical Care and its sale will allow us to further focus on delivering value in these key areas.

"The Board's expectations for the full year remain unchanged and we look forward to providing a trading update later in the year on the half year results."

[ali47fish] 19/5/2023 07:17

lombard does it again fromc 18 to 19pc- what dont we know?

[someuwin] 18/5/2023 08:11

Lombard Odier increase holding from 18.02% to 19.01%.

[blackhorse23] 18/4/2023 07:50

Bought yesterday GATC & going add more today

[al101uk] 05/4/2023 23:36

Tiny volume... odd?

[deadly] 05/4/2023 19:32

up 12% today, any news?

[grahamg8] 22/3/2023 17:57

Mr Market seems to think these are decent results, and I agree.

But what a truly awful RNS. Don't the Directors talk to each other and decide what subject each is going to cover? All of them seem obsessed with the NAL part of the business, and yet it represents just a small part of Consumer Legal Services. Should we equate 34905 enquiries with 8760 claims allocated to NAL? Or are enquiries and claims different animals? What proportion of new claims being processed go to JV Companies, I haven't a clue? How much cash is being generated from the JV's, haven't a clue?

Where is the, oh so simple table, Revenue, Operating Profits, this year (last year) vs Consumer Services NAL, JV, Critical Care, (the Bush part and the other bit if it exists or is it all Bush now, haven't a clue), Residential Property, Any other revenue earning part of the business if they exist, Central Expenses.

Results reports are supposed to inform investors and potential investors of the overall performance of a business. These seem to go out of their way to hide what is really going on.

[deadly] 24/1/2023 09:25

Decent results today:

Year ended 31 December FY2022 FY2021 Change
Group Revenue GBP41.5m GBP38.9m 6.5%
---------- ---------- -------
Operating Profit GBP4.8m GBP4.2m 15.7%
---------- ---------- -------
Profit Before Tax GBP0.6m GBP0.2m 163.8%
---------- ---------- -------
Net Debt GBP13.3m GBP15.5m -14.1%

[dalton247] 11/11/2022 18:48

83% of Operating profit goes to non-controlling interests i.e. not NAHL shareholders.

With a 0 pence EPS on £20m of revenue there is nothing reassuring about those results or P/E ratio.

Even Critical Care has gone backwards against a comparative that still included covid lockdowns.

A perennial business in transition.

[massimoj] 27/9/2022 10:17

Interesting and reassuring interim results this morning.

They are progressing well with their strategy of building up a book of WIP (work in progress) within their law firm and are balancing investment in cases with cash flow sensibly. Once the book reaches maturity (FY24), it should generate £2-3m per year in profits, which when added to the c. £3-4m+ profits from their other main division (provides Critical Care assessment and expert witness services), the group should be earning in excess of £5m per year. That's against a market cap of c.15m (EV of £29m). I hold.

[blackhorse23] 12/8/2022 22:07

Mcap too high ...

[ali47fish] 01/8/2022 16:14

where 's everyone here- update comments?